Continue your medications as prescribed
Many patients tolerate these medications well, especially when doses are increased slowly
This area will be relaxing and comfortable
Neeland, Linge, and Birkenfeld (2024), writing in Diabetes, Obesity and Metabolism , conclude that skeletal muscle changes with GLP-1 receptor agonist treatment appear adaptive: reductions in muscle volume are commensurate with what is expected given aging, disease status, and weight loss achieved, and improvements in insulin sensitivity and muscle fat infiltration likely contribute to improved muscle quality
Furthermore, western blot analysis was performed and an increased expression of an antioxidant enzyme, superoxide dismutase 2 (SOD2) following L-carnitine administration, was seen (Fig
Peptide therapy is an investment